SHERIDAN, WYOMING – November 7, 2024 – In an era marked by growing health concerns and disparities, Tanzania is taking proactive strides to bolster its healthcare system. Through strategic investment in medical education and capacity building, the nation is fostering a skilled healthcare workforce to address its unique challenges and improve the well-being of its citizens. A collaborative endeavor between the Tanzanian Ministry of Health, Siemens Healthineers, and Muhimbili National Hospital (MNH) has yielded a specialized training program for medical engineers and radiographers. Over the past two years, this initiative has empowered more than 100 healthcare professionals with advanced skills in operating state-of-the-art imaging equipment.

SHERIDAN, WYOMING – November 07, 2024 – In an effort to combat the largest blood shortage in a generation, Abbott and the Big Ten Conference have joined forces to launch "The We Give Blood Drive," a conference-wide competition aimed at increasing blood donations. This initiative taps into the competitive spirit of Big Ten universities and their fans, encouraging them to give back to their communities while vying for a $1 million prize and a trip to the 2024 Discover Big Ten Football Championship Game. The competition, which kicked off on September 26th, has already seen tremendous support, with over 8,000 Big Ten fans, students, and alumni donating blood.

Sydney Marathon Joins Abbott World Marathon Majors as 7th Race SHERIDAN, WYOMING – November 7, 2024 – The world of marathon running has expanded with the addition of the TCS Sydney Marathon presented by Asics to the Abbott World Marathon Majors (AWMM). Starting in 2025, Sydney will join the prestigious ranks of Tokyo, Boston, London, Berlin, Chicago, and New York in hosting one of the world's most renowned marathons.

SHERIDAN, WYOMING – November 07, 2024 – Abbott (NYSE: ABT) today announced significant strides in its pulsed field ablation (PFA) solutions within the electrophysiology field. The company has achieved key milestones, including the early completion of enrollment in the VOLT-AF IDE Study for the Volt™ PFA System and the initiation of the FOCALFLEX trial to evaluate the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ (SE), designed for treating paroxysmal atrial fibrillation. These advancements underscore Abbott's commitment to providing innovative solutions for abnormal heart rhythms like atrial fibrillation (AFib).

SHERIDAN, WYOMING – November 07, 2024 – GE HealthCare, a leading global medical technology and diagnostics company, is poised to announce its latest quarterly earnings before the market opens on Wednesday. Financial analysts are predicting an increase in both revenue and profits compared to the same period last year, signaling continued resilience amidst a challenging global economic landscape.

SHERIDAN, WYOMING – November 07, 2024-Roche (SIX: RO, ROG; OTCQX: RHHBY) has opened its new Pharma Research and Early Development Center (pRED) at its global headquarters in Basel. The center has 1,800 laboratory and office workplaces, bringing together researchers from different disciplines, explains Roche in a statement. The center’s inauguration was attended by Federal Councillor Guy Parmelin, Head of the Federal Department of Economic Affairs, Education and Research.

SHERIDAN, WYOMING – November 07, 2024 – Roche, a global pioneer in pharmaceuticals and diagnostics, is set to present a robust body of data at the upcoming 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego. With more than 40 abstracts spanning nine blood disorders, Roche's presence at ASH underscores its unwavering dedication to improving outcomes for individuals battling lymphoma.

SHERIDAN, WYOMING – November 7, 2024 – Roche, a global healthcare pioneer, has announced continued strong sales growth in the third quarter of 2024. The company's performance was driven by high demand for both its Pharmaceuticals and Diagnostics divisions, with Group sales increasing by 9% at constant exchange rates (CER). [cite: 1, 2, 3] “Our strong growth momentum continued in the third quarter, reflecting the high demand for our innovative medicines and diagnostic solutions and their positive impact on patients’ lives around the world,” said Roche CEO Thomas Schinecker. Pharmaceuticals Division

SHERIDAN, WYOMING – November 7, 2024– Alpine Endurance Team has wrapped up its 2024 FIA World Endurance Championship campaign, marking the end of a learning year for its A424 Hypercar. The team secured a fourth-place finish in the 8 Hours of Bahrain, a race marked by intense competition. This result solidified their fourth-place standing in the World Endurance Manufacturers' Championship.

SHERIDAN, WYOMING – November 7, 2024 – World Bicycle Relief, a global non-profit organization dedicated to providing access to transportation in developing countries, has announced that Giant Group, the parent company of Giant, Liv, Momentum, and CADEX, will receive the 2024 Trailblazer Award. This prestigious award recognizes organizations and individuals who have made significant contributions to improving lives through transportation.